Business Description
Medigen Vaccine Biologics Corp
ISIN : TW0006547003
Description
Medigen Vaccine Biologics Corp is a biopharmaceutical company focusing on developing and producing vaccines and biologics. It is engaged in developing IP-protected cell-culture technologies for vaccine manufacturing. The company develops vaccines and affordable biosimilars to prevent regional infectious diseases. The Group generates revenue from manufacturing and selling a range of Covid-19 vaccines and Covid-19 test kits and provides technical services on cellular therapy product quality and cell culture tests.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.84 | |||||
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 0.52 | |||||
| Debt-to-EBITDA | -2.33 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 4.41 | |||||
| Beneish M-Score | -3.37 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 207 | |||||
| 3-Year EBITDA Growth Rate | -16.1 | |||||
| 3-Year EPS without NRI Growth Rate | -13.3 | |||||
| 3-Year FCF Growth Rate | 14.2 | |||||
| 3-Year Book Growth Rate | 5.4 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.29 | |||||
| 9-Day RSI | 34.36 | |||||
| 14-Day RSI | 40.4 | |||||
| 6-1 Month Momentum % | -26.5 | |||||
| 12-1 Month Momentum % | -17.79 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.19 | |||||
| Quick Ratio | 1.98 | |||||
| Cash Ratio | 1.91 | |||||
| Days Inventory | 1287.88 | |||||
| Days Sales Outstanding | 89.28 | |||||
| Days Payable | 39.26 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.5 | |||||
| Shareholder Yield % | -0.14 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 61.39 | |||||
| Operating Margin % | -244.5 | |||||
| Net Margin % | -227.81 | |||||
| FCF Margin % | -100.22 | |||||
| ROE % | -23.92 | |||||
| ROA % | -15.81 | |||||
| ROIC % | -33.27 | |||||
| ROC (Joel Greenblatt) % | -48.69 | |||||
| ROCE % | -20.2 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 37.28 | |||||
| PB Ratio | 4.44 | |||||
| Price-to-Tangible-Book | 4.48 | |||||
| EV-to-EBIT | -15.56 | |||||
| EV-to-EBITDA | -17.97 | |||||
| EV-to-Revenue | 34.13 | |||||
| EV-to-FCF | -34.05 | |||||
| Price-to-Net-Current-Asset-Value | 8.29 | |||||
| Price-to-Net-Cash | 11.33 | |||||
| Earnings Yield (Greenblatt) % | -6.43 | |||||
| FCF Yield % | -2.65 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medigen Vaccine Biologics Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 448.224 | ||
| EPS (TTM) (NT$) | -3.112 | ||
| Beta | 1.01 | ||
| Volatility % | 43.08 | ||
| 14-Day RSI | 40.4 | ||
| 14-Day ATR (NT$) | 1.415412 | ||
| 20-Day SMA (NT$) | 53.005 | ||
| 12-1 Month Momentum % | -17.79 | ||
| 52-Week Range (NT$) | 48.05 - 81.5 | ||
| Shares Outstanding (Mil) | 328.61 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medigen Vaccine Biologics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medigen Vaccine Biologics Corp Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medigen Vaccine Biologics Corp Frequently Asked Questions
What is Medigen Vaccine Biologics Corp(ROCO:6547)'s stock price today?
The current price of ROCO:6547 is NT$51.00. The 52 week high of ROCO:6547 is NT$81.50 and 52 week low is NT$48.05.
When is next earnings date of Medigen Vaccine Biologics Corp(ROCO:6547)?
The next earnings date of Medigen Vaccine Biologics Corp(ROCO:6547) is .
Does Medigen Vaccine Biologics Corp(ROCO:6547) pay dividends? If so, how much?
Medigen Vaccine Biologics Corp(ROCO:6547) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers